| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/06/2011 | WO2011001122A2 Pyrazole derivatives, preparation thereof, and therapeutic use thereof |
| 01/06/2011 | WO2011001115A1 Novel 6-morpholin-4-yl-pyrimidin-4-(3h)-one derivatives, and the pharmaceutical preparation thereof as akt(pkb) phosphorylation inhibitors |
| 01/06/2011 | WO2011001114A1 Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors |
| 01/06/2011 | WO2011001113A2 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof |
| 01/06/2011 | WO2011001112A1 Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof |
| 01/06/2011 | WO2011001109A1 Methods and compositions for treating cancer |
| 01/06/2011 | WO2011001089A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/06/2011 | WO2011001088A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/06/2011 | WO2011001086A2 Use of interfering rna for treating an hiv infection |
| 01/06/2011 | WO2011001052A1 Novel conjugates, preparation thereof, and therapeutic use thereof |
| 01/06/2011 | WO2011001039A1 Micronised progesterone pharmaceutical composition and uses thereof |
| 01/06/2011 | WO2011000994A1 N-substituted n-phenetyl sulphonamide libraries for the identification of biological and pharmacological activity |
| 01/06/2011 | WO2011000993A1 N-phenyl-1-sulfonyl-2-pyrrolidine carboxamides libraries for the identification of biological and pharmacological activity |
| 01/06/2011 | WO2011000992A1 N-(1-phenyl-2-oxo-3-piperidyl)sulphonamide libraries for the identification of biological and pharmacological activity |
| 01/06/2011 | WO2011000946A1 Gymnemic acids for antifungal applications |
| 01/06/2011 | WO2011000945A2 Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns |
| 01/06/2011 | WO2011000930A1 L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin |
| 01/06/2011 | WO2011000929A1 Neurotoxins exhibiting shortened biological activity |
| 01/06/2011 | WO2011000915A1 Isoform-selective hcn blockers |
| 01/06/2011 | WO2011000905A1 Substituted 2-carboxamide cycloamino ureas |
| 01/06/2011 | WO2011000863A1 Sulfonamide derivatives for use in the treatment of skin conditions |
| 01/06/2011 | WO2011000855A1 2-carboxamide cycloamino ureas useful as pi3k inhibitors |
| 01/06/2011 | WO2011000811A2 Organic compounds |
| 01/06/2011 | WO2011000767A1 New medical use |
| 01/06/2011 | WO2011000765A1 New medical use |
| 01/06/2011 | WO2011000721A1 Inhibitors of microbial infections |
| 01/06/2011 | WO2011000593A1 Method for determining susceptibility of individuals to polyphenols |
| 01/06/2011 | WO2011000581A2 Raloxifene composition |
| 01/06/2011 | WO2011000565A1 Eltoprazine for the treatment of anxiety |
| 01/06/2011 | WO2011000564A1 Eltoprazine for the treatment of drug addiction |
| 01/06/2011 | WO2011000563A1 Eltoprazine for the treatment of weight disorders |
| 01/06/2011 | WO2011000562A1 Eltoprazine for the treatment of certain movement disorders |
| 01/06/2011 | WO2011000309A1 Use of puerarin in preparing medicine for treating p2x3-mediated pain/nervous system disease |
| 01/06/2011 | WO2011000218A1 Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders |
| 01/06/2011 | WO2011000210A1 Composition of permeation enhancer and use thereof in transdermal drug delivery system |
| 01/06/2011 | WO2011000208A1 Pharmaceutical composition containing dimethicone/ simethicone |
| 01/06/2011 | WO2011000116A1 Use of steroidal compounds for the conversion of normal b lymphocytes into immunoglobulin-secreting plasma cells |
| 01/06/2011 | WO2011000108A1 Compositions and methods for silencing apolipoprotein b |
| 01/06/2011 | WO2011000107A1 Novel lipid formulations for delivery of therapeutic agents to solid tumors |
| 01/06/2011 | WO2011000106A1 Improved cationic lipids and methods for the delivery of therapeutic agents |
| 01/06/2011 | WO2011000104A1 Fluorinated derivatives of 3-hydroxypyridin-4-ones |
| 01/06/2011 | WO2011000053A1 Medicinal carbohydrates for treatment of respiratory conditions |
| 01/06/2011 | WO2011000032A1 Sulfated polysaccharides having antiplasmodial activity and methods and products for identifying antiplasmodial activity |
| 01/06/2011 | WO2010132684A9 Inhibitors of inv(16) leukemia |
| 01/06/2011 | WO2010132554A3 Diaza heterocyclic compounds for phototherapy |
| 01/06/2011 | WO2010131118A3 Polymorphs of etravirine and processes for preparation thereof |
| 01/06/2011 | WO2010131038A3 Steroid containing composition and uses thereof |
| 01/06/2011 | WO2010130934A3 2-cycloamino-5-(pyridin-4-yl)imidazo[2,1-b][1,3,4]thiadiazole derivatives, preparation thereof, and therapeutic use thereof |
| 01/06/2011 | WO2010130773A3 Benzoxazolone derivatives as aldosterone symthase inhibitors |
| 01/06/2011 | WO2010129500A3 Nematocidal sulfonamides |
| 01/06/2011 | WO2010125462A3 Pentamidine combinations for treating cancer |
| 01/06/2011 | WO2010123699A3 Compositions, kits and methods for promoting ischemic and diabetic wound healing |
| 01/06/2011 | WO2010122575A3 Process for the preparation of pure paliperidone |
| 01/06/2011 | WO2010122571A3 A process for the selective methylation of erythromycin a derivatives. |
| 01/06/2011 | WO2010121351A8 Use of (hexenoyl trans-3)hgrf(1-44)nh2 and ritonavir in combination therapy |
| 01/06/2011 | WO2010121225A3 Method of treating disorders associated with protein kinase ck2 activity |
| 01/06/2011 | WO2010119102A3 Pharmaceutical composition containing proton pump inhibitor for treating dermatological autoimmune diseases |
| 01/06/2011 | WO2010114425A3 Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum |
| 01/06/2011 | WO2010114405A3 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same |
| 01/06/2011 | WO2010109084A3 9h-pyrrolo[2,3-b: 5,4-c'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof |
| 01/06/2011 | WO2010107251A3 Pharmaceutical composition used in prophylaxis or treatment of hyperproliferative skin conditions and malignant melanomas comprising pachastrissamine as active ingredient |
| 01/06/2011 | WO2010102192A3 Non-steroidal anti-inflammatory ophthalmic compositions |
| 01/06/2011 | WO2010101994A3 Gene fusion targeted therapy |
| 01/06/2011 | WO2010098625A3 Pharmaceutical preparation |
| 01/06/2011 | WO2010098600A3 Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same |
| 01/06/2011 | WO2010097626A3 Methylene blue derivatives |
| 01/06/2011 | WO2010096123A3 Amino acid salts of prostaglandins |
| 01/06/2011 | WO2010095041A3 Compositions, methods, and kits for treating influenza viral infections |
| 01/06/2011 | WO2010090498A3 Pharmaceutical composition and health food composition containing youngia denticulata extract, fraction thereof, or compound isolated therefrom as active ingredient for improving liver function |
| 01/06/2011 | WO2010090494A3 Medical use of 5-benzylaminosalicylic acid derivatives or salts thereof |
| 01/06/2011 | WO2010089361A3 Process for the preparation of a pharmaceutical composition comprising ezetimibe |
| 01/06/2011 | WO2010089104A3 Resveratrol compositions |
| 01/06/2011 | WO2010081825A3 Pirenzepine as an agent in cancer treatment |
| 01/06/2011 | WO2010075266A3 Intranasal desmopressin administration |
| 01/06/2011 | WO2010056985A8 Treatment of proteinopathies using a farnesyl transferase inhibitor |
| 01/06/2011 | WO2010053978A3 Modulation of toll-like receptor 5 expression by antisense oligonucleotides |
| 01/06/2011 | WO2010034105A8 Hepatitis c inhibitor compounds |
| 01/06/2011 | WO2010028216A3 Porphyrazine optical and dual optical/mr contrast and therapeutic agents |
| 01/06/2011 | WO2010000364A8 Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
| 01/06/2011 | WO2009144093A8 Hydroxytyrosol benefits mitochondria |
| 01/06/2011 | WO2009135593A3 Solid pharmaceutical formulation with delayed release |
| 01/06/2011 | WO2008118762A9 Methods and packages to enhance safety when using imiquimod to treat children diagnosed with skin disorders |
| 01/06/2011 | US20110004951 Methods and compositions for identifying compounds that inhibit hiv-1 subunit-specific reverse transcriptase |
| 01/06/2011 | US20110004169 Preparation and Use of Sleeve and Micro-Encapsulated Topical Analgesic Patch For Treating Pain |
| 01/06/2011 | US20110004164 Non-sedating antihistamine injection formulations and methods of use thereof |
| 01/06/2011 | US20110004006 Aminocyclohexyl ether compounds and uses thereof |
| 01/06/2011 | US20110004000 Mitotic Kinesin Inhibitor |
| 01/06/2011 | US20110003987 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors |
| 01/06/2011 | US20110003897 Methods of engineering polar drug particles with surface-trapped hydrofluoroalkane-philes |
| 01/06/2011 | US20110003896 Dimeric double metal salts of (-)-hydroxycitric acid, methods of making and uses of same |
| 01/06/2011 | US20110003895 Pharmacology of Visual Cycle Modulators |
| 01/06/2011 | US20110003894 Dermatological compositions comprising retinoids, dispersed benzoyl peroxide and carrageenans |
| 01/06/2011 | US20110003893 Aqueous loxoprofen-containing patches |
| 01/06/2011 | US20110003892 All-trans retinoid esters as active pharmaceutical ingredients, oral and topical dosage form compositions thereof, and methods of treating skin conditions thereof |
| 01/06/2011 | US20110003891 Novel use of zinc n-acetyltaurinate |
| 01/06/2011 | US20110003890 Use of angiogenesis antagonists in conditions of abnormal venous proliferation |
| 01/06/2011 | US20110003889 Membrane fusion inhibitor |
| 01/06/2011 | US20110003888 Hops extraction methods and mixtures |
| 01/06/2011 | US20110003887 Treating oncogenic ras driven cancers |
| 01/06/2011 | US20110003886 Selection of rna aptamers as anti-malaria agents |